Hzymes help’s to get first mRNA vaccine IND approved by the US FDA Congratulations to Zhejiang Haichang Biotechnology Co., Ltd. for obtaining the approval of the US FDA (IND: 28424) for the IND application of the Novel coronavirus mRNA vaccine booster project, which is the first mRNA vaccine project approved by the US FDA in China. US FDA Hzymes Biotech provided high-quality raw materials for the project and …
Hzymes help’s to get first mRNA vaccine IND approved by the US FDA Read More »